Education
About Us
Working with TipRanks
Follow Us
Multiplan Corp (MPLN)
NYSE:MPLN
Top Page
MultiPlan
(NYSE:MPLN)
47Neutral
MultiPlan (MPLN) vs. S&P 500 (SPY)
Market Cap
$340.00M
Dividend YieldN/A
Average Volume (3M)173.53K
Price to Earnings (P/E)―
Beta (1Y)1.79
Revenue Growth-1.66%
EPS Growth-114.66%
CountryUS
Employees2,800
SectorHealthcare
Sector Strength57
IndustryHealthcare Providers & Services
Share Statistics
EPS (TTM)-101.95
Shares Outstanding16,198,025
10 Day Avg. Volume227,899
30 Day Avg. Volume173,534
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.40
Price to Cash Flow (P/CF)1.30
P/FCF Ratio2.30
Enterprise Value/Market Cap13.42
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit6.60
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$21.00Price Target Upside0.05% Upside
Rating ConsensusHold
Number of Analyst Covering1
MultiPlan Business Overview & Revenue Model
Company DescriptionChurchill Capital Corp III is a blank check company.
How the Company Makes MoneyMultiPlan generates revenue by providing a suite of services designed to help healthcare payers manage and reduce their medical costs. The company's key revenue streams include fees from network-based solutions, where they offer access to a broad network of healthcare providers at negotiated rates, analytics-based solutions that use data analysis to optimize pricing and identify cost-saving opportunities, and payment integrity services that ensure accurate and appropriate payment of healthcare claims. Significant partnerships with healthcare payers and providers, as well as a large network of healthcare practitioners, contribute to MultiPlan's earnings by ensuring a wide client base and extensive service implementation.
MultiPlan Financial Statement Overview
Summary
Income Statement
Balance Sheet
Cash Flow
| Breakdown | ||||
| Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|
| Income Statement | Total Revenue | |||
| 930.62M | 961.52M | 1.08B | 1.12B | 937.76M | Gross Profit |
| 691.22M | 306.04M | 875.62M | 942.31M | 619.09M | EBIT |
| -1.39B | 173.40M | 302.99M | 386.12M | -105.17M | EBITDA |
| -1.01B | 651.93M | 158.32M | 814.99M | 192.41M | Net Income Common Stockholders |
| -1.65B | -91.70M | -572.91M | 102.08M | -529.63M |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
| 16.85M | 71.55M | 334.05M | 185.33M | 126.75M | Total Assets |
| 5.15B | 6.96B | 7.37B | 8.22B | 8.28B | Total Debt |
| 4.54B | 4.57B | 4.78B | 4.93B | 4.61B | Net Debt |
| 4.52B | 4.50B | 4.45B | 4.74B | 4.49B | Total Liabilities |
| 5.07B | 5.26B | 5.58B | 5.88B | 5.69B | Stockholders Equity |
| 84.02M | 1.71B | 1.79B | 2.34B | 2.59B |
| Cash Flow | Free Cash Flow | |||
| -10.51M | 62.87M | 282.63M | 320.10M | 306.56M | Operating Cash Flow |
| 107.62M | 171.72M | 372.36M | 404.69M | 377.37M | Investing Cash Flow |
| -118.12M | -249.79M | -104.45M | -228.38M | -210.84M | Financing Cash Flow |
| -41.31M | -180.99M | -115.74M | -114.68M | -61.60M |
MultiPlan Technical Analysis
Negative
20.99
Price Trends
18.89
Negative
13.58
Positive
13.56
Positive
Market Momentum
-0.03
Positive
41.19
Neutral
41.63
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MPLN, the sentiment is Negative. The current price of 20.99 is below the 20-day moving average (MA) of 24.07, above the 50-day MA of 18.89, and above the 200-day MA of 13.56, indicating a neutral trend. The MACD of -0.03 indicates Positive momentum. The RSI at 41.19 is Neutral, neither overbought nor oversold. The STOCH value of 41.63 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for MPLN.
MultiPlan Peers Comparison
Overall Rating
UnderperformOutperform
Sector (52)
Financial Indicators
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | $18.87B | 16.89 | 26.72% | ― | 16.71% | 12.23% | |
74 Outperform | $31.68B | 10.22 | 12.59% | ― | 8.85% | 33.30% | |
69 Neutral | $35.61B | 29.55 | 10.09% | 1.37% | 10.09% | -12.18% | |
69 Neutral | $548.34B | 38.66 | 15.88% | 2.10% | 8.68% | ― | |
52 Neutral | $5.35B | 3.96 | -42.60% | 2.86% | 17.58% | 1.27% | |
47 Neutral | $340.00M | ― | -183.57% | ― | -1.66% | -114.66% |
* Healthcare Sector Average
Performance Comparison
MPLN
MultiPlan
18.26
-8.40
-31.51%
CNC
Centene
60.16
-14.98
-19.94%
HUM
Humana
258.48
-56.95
-18.05%
MOH
Molina Healthcare
318.04
-25.17
-7.33%
UNH
UnitedHealth
399.92
-86.68
-17.81%
MultiPlan Earnings Call Summary
Earnings Call Date:Feb 25, 2025
(Q4-2024)
| % Change Since: -28.12%|
Next Earnings Date:May 07, 2025
Earnings Call Sentiment Neutral
The earnings call highlighted significant strategic advancements, including successful debt refinancing, major contract wins, and product launches, which are offset by challenges such as a decline in revenue and dependence on a single client's performance. Overall, the company is optimistic about its future growth and transformation efforts, although it faces headwinds in its core business segments.Q4-2024 Updates
Positive Updates
Successful Debt Refinancing
Claritev successfully refinanced its entire debt structure, extending maturities by approximately three years with a 99.75% participation outcome, demonstrating commitment to investors and confidence in the company's Vision 2030.
Record Contract Booking
Closed the largest-ever single contract booking of $34 million in total contract value, with 12 similar enterprise sale opportunities in the pipeline, indicating strong market demand and a new innovative business model.
New Product Launches and Market Expansion
Launched CompleteVue for providers and BenInsights for employers, with 39 new opportunities in the pipeline for 2025, contributing to market expansion and increased addressable market size.
Chief AI Officer Appointment
Appointed the first Chief AI Officer, underlining the company's commitment to technology and talent, with plans to leverage AI for product innovation and operational efficiencies.
Positive Client Renewal
Successfully renewed a major client for three additional years at the current value, reflecting the ongoing strength of core services and client relationships.
Negative Updates
Revenue Decline
FY 2024 revenue was $930.6 million, down 3.2% from FY 2023, primarily due to the impact of one large client, impacting overall financial performance.
Pressure on Core Business
Network-based revenues declined by 17.1%, and payment and revenue integrity revenues decreased by 1.6%, demonstrating challenges in maintaining growth in core segments.
Single-Client Impact
Continued challenges with a single client significantly affected revenue, with expectations for stabilization only by 2025, highlighting dependency on key clients.
Company Guidance
During the Claritev Corporation Fourth Quarter 2024 Earnings Call, CEO Travis Dalton and CFO Doug Garis provided guidance for 2025, highlighting a strategic focus on transformation and growth. They announced a revenue projection that is expected to be slightly down to flat for 2025, with an adjusted EBITDA margin target between 62.5% and 63.5%. The company anticipates a net revenue retention rate of approximately 97% for its core segments, despite the anticipated decline of one large client. Claritev expects strong double-digit growth in its HST and Data and Decision Science business areas, driven by a 20% growth in bookings. The company is also pursuing a Rule of 70 target, combining adjusted EBITDA margin and revenue growth percentage, as a medium- to long-term goal. With a focus on modernizing operations, Claritev aims to achieve a 10% to 15% cost reduction and improve its technology platform and business processes. The guidance reflects a strategy to balance cost efficiencies while pursuing new market opportunities and enhancing product offerings.MultiPlan Corporate Events
Executive/Board Changes
MultiPlan Announces Board Leadership Changes and Advisory Role
Neutral
Dec 31, 2024
MultiPlan Corporation announced the resignation of Dale White from his role as Executive Chair of the Board of Directors, effective December 31, 2024. Following his departure, White will continue to serve as a director on the board and will take on a consulting role as a Strategic Advisor. Travis Dalton, the current President and CEO, has been appointed as the new Chair of the Board. The transition includes a retirement agreement detailing White’s compensation and advisory responsibilities.
Private Placements and FinancingBusiness Operations and Strategy
MultiPlan Announces Comprehensive Debt Refinancing Plan
Positive
Dec 26, 2024
MultiPlan Corporation announced a comprehensive refinancing plan to extend the maturities of its entire debt capital structure, with the earliest maturity pushed to 2030. This move, backed by broad investor support, aims to support the company’s Vision 2030 transformation plan by enhancing its capital structure, allowing for continued investment in business operations. The Transaction Support Agreement, involving approximately 78% of MultiPlan’s existing funded debt, outlines a series of transactions to exchange existing debt for new terms, eliminate certain covenants, and release collateral, thereby reorganizing the company’s capital structure for sustainable long-term growth.
Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.